Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder
NCT ID: NCT05373719
Last Updated: 2025-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
112 participants
OBSERVATIONAL
2022-09-30
2027-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
International CDKL5 Clinical Research Network
NCT05558371
International CDKL5 Registry
NCT04486768
Neuropsychologic, Neuroradiologic, Endocrinologic, and Genetic Aspects of Klinefelter Syndrome
NCT00999310
Genetic Analysis of Oculocerebrorenal Syndrome of Lowe
NCT00359515
Natural History Study of GEMIN-5 Related Neurodevelopmental Disorder
NCT06776341
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
0-2 Years of Age
Patients from birth to 2 years of age at time of study entry
No intervention; observational
No intervention; observational
3-5 Years of Age
Patients aged 3 to 5 years at time of study entry
No intervention; observational
No intervention; observational
6-12 Years of Age
Patients aged 6 to 12 years at time of study entry
No intervention; observational
No intervention; observational
13-55 Years of Age
Patients aged 13 to 55 years at time of study entry
No intervention; observational
No intervention; observational
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention; observational
No intervention; observational
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Ages newborn to 55 years old
3. Parent/Caregiver who is willing and capable of providing written informed consent
4. Parent/caregiver lives with or has daily contact with study participant and able to provide consistent information across the study
Exclusion Criteria
2. Any condition that, in the opinion of the investigator, would put the patient at undue risk or make it unsafe for the patient to participate
3. Any condition which would make the individual or the caregiver, in the opinion of the investigator, unsuitable for the study
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Loulou Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCLA Mattel Children's Hospital
Los Angeles, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
Center for Rare Neurological Diseases
Norcross, Georgia, United States
Boston Children's Hospital
Boston, Massachusetts, United States
New York University
New York, New York, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
The Cleveland Clinic
Cleveland, Ohio, United States
Childrens Hospital of Philadlephia Division of Neurology
Philadelphia, Pennsylvania, United States
Baylor College of Medicine
Houston, Texas, United States
Alberta Children's Hospital, Pediatric Epilepsy and Child Neurology
Calgary, , Canada
The Hospital of Sick Children
Toronto, , Canada
Hopital Necker- Enfants Malades
Paris, , France
DRK Berlin - Epilepsiezentrum und Neuropädiatrie
Berlin, , Germany
Schön Klinik Vogtareuth
Vogtareuth, , Germany
Azienda Ospedaliero-Universitaria Meyer
Florence, , Italy
Fondazione Policlinico Universitario A Gemelli, IRCCS
Roma, , Italy
Ospedale Pediatrico Bambino Gesù
Rome, , Italy
Azienda Ospedaliera Universitaria Integrata di Verona
Verona, , Italy
Hospital Infantil Universitario Niño Jesús
Madrid, , Spain
Ruber Internacional Hospital
Madrid, , Spain
Hospital UniversitarioVithas Madrid
Madrid, , Spain
Ruber Internacional Hospital
Madrid, , Spain
Mediclinic
Dubai, , United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LLF001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.